Top Blue Chip Stocks For 2019

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-637816771&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/637816771/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

With earnings season in the rear-view and the end of the first quarter looming, you&a;rsquo;re probably asking yourself &l;i&g;one thing&l;/i&g; right now&a;hellip;

&a;hellip; just how good is the stock market?

I&a;rsquo;ll give you the answer (which I think you&a;rsquo;ll like) in a moment.

Then I&a;rsquo;ll show you 2 funds whose portfolios are packed with familiar stocks, including &l;b&g;Apple&l;/b&g;. Both funds are poised for strong gains in 2018 while handing you fat cash payouts up to 8.8%!

&l;b&g;Finding Bargains in a Surprising Place&l;/b&g;

First, if you&a;rsquo;re like most folks, you might feel queasy about &l;i&g;any&l;/i&g; stocks&a;mdash;including &a;ldquo;reliable&a;rdquo; blue chips&a;mdash;after the stomach-churning drops we suffered in February.

Top Blue Chip Stocks For 2019: ABAXIS Inc.(ABAX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 16 percent to $83.08. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

  • [By Shane Hupp]

    Abaxis Inc (NASDAQ:ABAX) has received a consensus recommendation of “Hold” from the thirteen brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $67.00.

  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 16 percent to $82.95. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

Top Blue Chip Stocks For 2019: Kamada Ltd.(KMDA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Kamada Ltd. (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $24.02 million.

    Concordia International Corp. (NASDAQ: CXRX) is estimated to report quarterly earnings at $0.06 per share on revenue of $143.80 million.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Kamada (KMDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Kamada Ltd. (NASDAQ:KMDA) – Stock analysts at Jefferies Group dropped their FY2020 earnings estimates for shares of Kamada in a research report issued on Tuesday, May 15th. Jefferies Group analyst R. Denhoy now anticipates that the biotechnology company will earn $0.61 per share for the year, down from their previous forecast of $0.62. Jefferies Group also issued estimates for Kamada’s FY2021 earnings at $0.36 EPS.

  • [By Garrett Baldwin]

    Retail stocks are in focus after the U.S. Census Bureau released monthly sales figures before the bell Tuesday. The bureau said that retail sales increased by 0.3% in April, a figure that matched trade expectations. Markets had expected consumer spending to increase, however home improvement sales were not the major factor that most expected. This was evident from The Home Depot’s earnings report. Markets are increasingly optimistic over U.S. trade negotiations with China. Chinese President Xi Jinping’s No. 1 economic advisor will visit the United States this week to continue the nation’s dialogue with America. In addition, roughly 100 companies and trade associations will be sounding off to the Trump administration about the potential impact of tariffs in the Chinese markets.
    Stocks to Watch Today: TSLA, AMZN, GS
    Amazon.com Inc. (Nasdaq: AMZN) is in focus thanks to tax policy in Seattle. On Monday, the Seattle’s City Council passed a bill that will tax Amazon and 131 other companies $275 per employee each year in order to create a fund to address homelessness in the Seattle. The tax is half what was originally proposed and remains a contentious issue for Amazon, which is the city’s biggest employer. Goldman Sachs Group (NYSE: GS) is sounding the alarm about the state of the markets. The company warned that the U.S. budget deficit is increasing while America’s unemployment rate is falling. This hasn’t occurred since the World War II. The bank believes that the combination of the two could cause the Fed to spike interest rates in the near future. This comes at a time when the Fed has already lost control of interest rates. Look for additional earnings reports from Eagle Materials Inc. (NYSE: EXP), Bitauto Holding Ltd.(Nasdaq: BITA), Virtusa Corp. (Nasdaq: VRTU), Global Eagle Entertainment Inc.(Nasdaq: ENT), and Kamada Ltd. (Nasdaq: KMDA).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

Top Blue Chip Stocks For 2019: Cambrex Corporation(CBM)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Cambrex Corp. (NYSE: CBM) was founded in 1981 and is a leading supplier of generic active pharmaceutical ingredients (APIs).

    Cambrex has more than 100 generic APIs, and 90 of them are commercially sold.

Top Blue Chip Stocks For 2019: Luna Innovations Incorporated(LUNA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Luna Innovations (NASDAQ:LUNA) major shareholder Clinic Carilion sold 6,100 shares of Luna Innovations stock in a transaction on Friday, May 25th. The shares were sold at an average price of $3.41, for a total transaction of $20,801.00. Following the completion of the sale, the insider now owns 2,054,385 shares of the company’s stock, valued at approximately $7,005,452.85. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

  • [By Logan Wallace]

    PRA Health Sciences (NASDAQ: PRAH) and Luna Innovations (NASDAQ:LUNA) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Luna Innovations (LUNA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published.